Vanderbilt-Ingram Cancer Center clinical trial pipeline

4 trials changed in the last 30 days: 0 stopped, 4 with notable changes, 0 with minor changes only.

1. Notable

   Intrathecal Cytarabine and Hydrocortisone for the Early Treatment…Intrathecal Cytarabine and Hydrocortisone for the Early Treatment of ICANS in Patients Undergoing CAR T Therapy for Non Hodgkin Lymphoma

   Primary endpoint(s) modified

   Also in this update: Recruitment opened; Primary completion moved earlier from Oct 1, 2029 to Mar 1, 2028

   Vanderbilt-Ingram Cancer Center·Phase 2· NCT07763210· Registry history of NCT07763210 on ClinicalTrials.gov (opens the registry)

   Oct 2, 2026

2. Notable

   Casdatifan · Refractory Metastatic Clear Cell Renal Cell Carcinoma

   Phase changed: Early Phase 1 → Phase 1

   Also in this update: Recruitment opened

   Vanderbilt-Ingram Cancer Center·Phase 1· NCT07748988· Registry history of NCT07748988 on ClinicalTrials.gov (opens the registry)

   Sep 25, 2026

3. Notable

   Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently…Window Trial of Intratumoral (IT) Neoadjuvant Fluorescently Labelled Nivolumab (nivo800) in Head and Neck Squamous Cell Carcinoma (HNSCC)

   Recruitment opened

   Vanderbilt-Ingram Cancer Center·Early Phase 1· NCT07741565· Registry history of NCT07741565 on ClinicalTrials.gov (opens the registry)

   Oct 19, 2026

4. Notable

   Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted…Panitumumab-IRDye800 and [18F]NOTA-ABY-030 for Targeted Dual-Modality Imaging (TDMI) in Head and Neck Squamous Cell Carcinoma

   Recruitment opened

   Vanderbilt-Ingram Cancer Center·Phase 1· NCT07741643· Registry history of NCT07741643 on ClinicalTrials.gov (opens the registry)

   Oct 19, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.